Kelly Financial Services’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-65
| Closed | -$2.51K | – | 344 |
|
|
2024
Q2 | $2.51K | Hold |
65
| – | – | ﹤0.01% | 564 |
|
|
2024
Q1 | $2.77K | Buy |
65
+1
| +2% | +$43 | ﹤0.01% | 556 |
|
|
2023
Q4 | $2.38K | Buy |
64
+1
| +2% | +$37 | ﹤0.01% | 560 |
|
|
2023
Q3 | $2.3K | Hold |
63
| – | – | ﹤0.01% | 538 |
|
|
2023
Q2 | $2.24K | Buy |
63
+1
| +2% | +$36 | ﹤0.01% | 542 |
|
|
2023
Q1 | $2.22K | Sell |
62
-36
| -37% | -$1.29K | ﹤0.01% | 520 |
|
|
2022
Q4 | $3.43K | Sell |
98
-160
| -62% | -$5.61K | ﹤0.01% | 450 |
|
|
2022
Q3 | $7.59K | Sell |
258
-80
| -24% | -$2.35K | ﹤0.01% | 350 |
|
|
2022
Q2 | $18.4K | Buy |
338
+241
| +248% | +$13.1K | 0.01% | 262 |
|
|
2022
Q1 | $5.27K | Buy |
97
+1
| +1% | +$54 | ﹤0.01% | 424 |
|
|
2021
Q4 | $5.29K | Buy |
96
+38
| +66% | +$2.1K | ﹤0.01% | 431 |
|
|
2021
Q3 | $2.79K | Sell |
58
-2,240
| -97% | -$108K | ﹤0.01% | 480 |
|
|
2021
Q2 | $72K | Buy |
2,298
+2,241
| +3,932% | +$70.2K | ﹤0.01% | 417 |
|
|
2021
Q1 | $2.53K | Buy |
57
+1
| +2% | +$44 | ﹤0.01% | 483 |
|
|
2020
Q4 | $2.58K | Sell |
56
-10
| -15% | -$460 | ﹤0.01% | 441 |
|
|
2020
Q3 | $3.12K | Hold |
66
| – | – | ﹤0.01% | 392 |
|
|
2020
Q2 | $3.39K | Hold |
66
| – | – | ﹤0.01% | 376 |
|
|
2020
Q1 | $3.15K | Hold |
66
| – | – | ﹤0.01% | 348 |
|
|
2019
Q4 | $3.9K | Hold |
66
| – | – | ﹤0.01% | 335 |
|
|
2019
Q3 | $3.54K | Buy |
+66
| New | +$3.54K | ﹤0.01% | 333 |
|